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Summary In a case-control study in northeastern Italy hepatitis C virus infection seemed to increase by about 50-fold the risk of non-
Hodgkin's lymphoma involving the liver and major salivary glands (i.e. largerthan that for hepatocellular carcinoma) and by about fourfold the
risk of lymphomas at other sites.
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Chronic hepatitis C virus (HCV) infection has been identified as
the causative agent of different chronic liver diseases as well as
hepatocellular carcinoma (HCC) (IARC, 1994), even in the
absence ofcirrhotic lesions (De Mitri et al, 1995). HCV infection
has been associated with certain extrahepatic manifestations,
particularly mixed cryoglobulinaemia (MC), membranoprolifera-
tive glomerulonephritis, porphyria cutanea tarda and, possibly,
autoimmune thyroiditis and Sjogren's syndrome (Gumber and
Chopra, 1995). The demonstration of HCV in type II mixed
cryoglobulins with monoclonal rheumatoid factor has led to the
hypothesis that mixed cryoglobulins result from chronic stimula-
tion by HCV of a population of B cells (Agnello, 1995; Sansonno
et al, 1996). Benign proliferation of B cells progresses to frank
malignancy in a proportion of patients (Agnello, 1995;
Monteverde et al, 1995).
It has, thus, been hypothesized that HCV may be involved in the
aetiology of B-cell non-Hodgkin's lymphoma (NHL). At least
eight investigations from Italy, including over 1300 patients,
reported that approximately one-fourth (range 9-40%) of patients
with B-cell NHL were positive for HCV antibodies (Ferri et al,
1994; Cavanna et al, 1995; Mazzaro et al, 1996; Musto et al, 1996;
Pioltelli et al, 1996; Silvestri et al, 1996; De Rosa et al, 1997;
Luppi et al, 1997). Although most studies did not include a control
group, HCV positivity was many times higher than in age-
comparable groups of the Italian population (i.e. prevalence of
HCV about 3%; Bellentani et al, 1994).
HCV-driven chronic inflammation and lymphoproliferation
may be especially relevant at certain lymphoma sites. Lymphoid
hyperplasia is often found in liver biopsies from HCV-infected
individuals (Monteverde et al, 1995). Experimental and clinical
studies have also demonstrated HCV tropism for salivary epithe-
lial cells in both chronic inflammatory and NHL salivary lesions
(De Vita et al, 1995; Koike et al, 1997). Furthermore, it has been
suggested that HCV infection may be involved, in addition to
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Helicobacter pylori, in gastric lymphoproliferation, although
findings on HCV infection in mucosa-associated lymph tissue
(MALT) lymphomas of the stomach have not been consistent
(Luppi et al, 1996; Pioltelli et al, 1996; De Vita et al, 1997;
Silvestri et al, 1997).
On the basis of these preliminary observations, we designed a
case-control study to evaluate the association with HCV infection
at specific NHL locations. For comparative purposes, a group of
HCC was also included.
MATERIALS AND METHODS
The present case-control study was based on newly diagnosed
incident cancer patients, all HIV negative, diagnosed at Aviano
Cancer Centre and the nearby Pordenone General Hospital, north-
eastern Italy, between January 1994 and June 1997.
With respect to B-cell NHL at sites that may be most specifi-
cally associated with HCV proliferation, we identified nine cases
with involvement of the liver, and seven with involvement of the
salivary glands at NHL onset (mean age 62 years). In five ofthese
cases, either the liver (two cases) or the major salivary gland(s)
(three cases) were the only NHL localization, as established by
accurate staging procedures (De Vita et al, 1997). In the remaining
cases, other tissues were concomitantly involved (the spleen and
distant lymph nodes in four cases each and bone marrow in three
cases). According to the Working Formulation (The non-
Hodgkin's Lymphoma Pathologic Classification Project, 1982),
they included one low-grade, 13 intermediate-grade and two other
or unspecified NHL. None of the patients with salivary gland
lymphoma suffered from Sjogren's syndrome. For each case of
liver and salivary gland NHL, five concurrent cases of histologi-
cally confirmed B-cell NHL at nodal or other extranodal locations
at onset were identified in the hospital discharge lists, group-
matched by gender and age at diagnosis (±5 years). Among these,
all incident cases of primary gastric MALT lymphoma were
included. Eventually, on account of a few patients with missing
information about HCV status, 68 such NHL (median age 61
years) could be included, including 15 gastric lymphomas. Sixteen
were classified as low grade, 41 as intermediate grade, eight as
high grade, and three as other or unspecified NHL.
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Table 1 Distribution of sociodemographic characteristics and history of selected diseases and medical procedures for 84 cases of non-
Hodgkin's lymphoma, 27 of hepatocellular carcinoma and 73 controls. Aviano, Italy, 1994-97
Non-Hodgkin's Hepatocellular Controls
lymphoma carcinoma
Liver, salivary
glands Others
No. (%) No. (%) No. (%) No. (%)
Sex
Male 9 (56) 34 (50) 18 (67) 34 (47)
Female 7 (44) 34 (50) 9 (33) 39 (53)
Age (years)
<50 1 (6) 8 (12) 1 (4) 6 (8)
50-59 5 (31) 21 (31) 6 (22) 15 (21)
60-69 5 (31) 19 (28) 14 (52) 30 (41)
>70 5 (31) 20 (29) 6 (22) 22 (30)
Birthplace
Northern Italy 11 (69) 57 (84) 23 (85) 68 (93)
Central and southern Italy 5 (31)b 11 (16) 4 (15) 5 (7)
Smokinga
Never 10 (67) 33 (55) 11 (50) 29 (53)
Ever 5 (33) 27 (45) 11 (50) 26 (47)
Blood transfusions
Never 13 (81) 55 (81) 12 (44) 58 (79)
Ever 3 (19) 13 (19) 15 (56)b 15 (21)
Surgical procedures
Never 4 (25) 28 (41) 13 (48) 28 (38)
Ever 12 (75) 40 (59) 14 (52) 45 (62)
Alcohol abuse
No 15 (94) 66 (97) 19 (70) 73 (100)
Yes 1 (6) 2 (3) 8 (30)b -
HBsAga
Negative 15 (100) 61 (97) 19 (83) 56 (100)
Positive 0 (0) 2 (3) 4 (17)b 0 (0)
aSum of strata does not add up to the total because of missing values. X2, > 3.84, P < 0.05, compared with controls.
Table 2 Odds ratio and corresponding 95% confidence intervals (Cl) of non-Hodgkin's lymphoma and hepatocellular carcinoma by
hepatitis C virus (HCV) infection. Aviano, Italy, 1994-97
HCV infection
Positive Negative
No. (%) No. Odds ratioa 95%CI
Controls 3 (4.1) 70 1b -
Non-Hodgkin's lymphoma
Liver 7 (77.8) 2 51.48 9.27-285.81
Salivary glands 4 (57.1) 3 5
Gastric 3 (20.0) 12 4.33 1.06-17.73
Other 6 (11.3) 47 J
Hepatocellular carcinoma 11 (40.7) 16 21.86 4.78-99.94
aDerived from unconditional multiple regression equations including terms for age, sex and birthplace. bReference category.
Five control subjects, group-matched by gender and age, were become routine in the study years. Haemolymphopoietic
also identified for each case ofliver and salivary gland NHL from neoplasms were not included in the control group. Seventy-three
discharge lists of those wards of Aviano Cancer Centre and had valid information on HCV status and were included (median
Pordenone General Hospital where search for HCV antibodies had age 64 years). In the control group, there were 13 histologically
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confirmed cancers of the ovary, 14 of the uterus, 13 of the
colon-rectum, ten of the pancreas, eight of the lung, six of the
stomach, four ofthe oesophagus and five ofother sites. Finally, all
HCC patients diagnosed in 1994-97 in the study hospitals were
included (i.e. 27, median age 63 years).
For each study subject sociodemographic information, lifestyle
habits, and history of selected diseases and medical procedures
were extracted from medical records (Table 1). Anti-HCV anti-
bodies were tested by means of a second-generation enzyme-
linked immunosorbent (ELISA) technique (HCV 2.0, Ortho
Diagnostic Systems, Raritan, NJ, USA). Confirmatory tests
included recombinant-based immunoblot assay (Chiron RIBA
second generation, Ortho Diagnostic Systems) in all cases and
serum HCV RNA amplification in most ofthe cases (De Vita et al,
1995). Great attention was paid to make sure that all medical
procedures mentioned in Table 1 did not refer to diseases or proce-
dures subsequent to cancer diagnosis.
The relationship between NHL and HCC and HCV infection was
assessed by means of odds ratios (OR) and corresponding 95%
confidence intervals (Breslow and Day, 1980). Unconditional
multiple logistic regression equations included terms for age, gender
andbirthplace. Birthplace was included because ahigherprevalence
ofHCV infection has beenreportedin southem Italy (Guadagnino et
al, 1997) than in northem Italy (Bellentani et al, 1994).
RESULTS
Table 1 shows a few significant differences in the distribution of
the three groups ofcases and the control group according to certain
characteristics. Whereas a larger percentage of liver and salivary
gland NHL cases were born incentral and southem Italy, an excess
ofblood transfusions and alcohol abuse was reported for HCC, but
not NHL, cases compared with control subjects. Among HCC
cases, 17% were carriers of hepatitis B virus superficial antigen
(HBsAg), compared with none of liver and salivary gland NHL
and control subjects, and with 3% ofother NHL cases.
HCV infection was detected significantly more frequently
among NHL and HCC cases than among control subjects (Table
2). Risks, however, were greater for liver and salivary gland NHL
(OR 51.5) and HCC (OR 21.9) than forother NHL cases (OR 4.3).
None ofsix subjects positive for HBsAg who were tested for HCV
antibodies had positive results.
Inclusion of terms for education, blood transfusions and HBV
infection did not modify the ORs as presented.
DISCUSSION
The present study confirms several investigations that have shown
higher than expected prevalence of HCV infection in B-cell NHL
patients. The presence of an appropriate control group and of
information on several correlates of HCV infection allowed a
better quantification ofthe risks and adjustment for characteristics
(e.g. birthplace, blood transfusion, etc.), which may have
confounded the association with NHL in some previous studies.
NHL represents a heterogeneous group of malignancies,
possibly with different aetiologies (Scherr and Mueller, 1996). The
present study was too small to compare different NHL types, but
provides some evidence that HCV may be especially relevant to
B-cell lymphoid proliferation in the liver and salivary glands
(De Vita et al, 1995, 1997). Previously, a strong association of
HCV infection with immunocytoma has been suggested (Silvestri
et al, 1997), although the prevalence was not as high as in the NHL
cases localized at the liver and major salivary glands reported
herein. Thus, as already hypothesized (Agnello, 1995; De Vita et
al, 1995), the role of HCV in the development of NHL involving
liver or salivary glands may be similar to that of Helicobacter
pylori in gastric MALT lymphomas. Conversely, gastric NHL
resembled other NHLs with respect to HCV prevalence.
An association between HCV and NHL has also been reported
in Japan (Izumi et al, 1996), Israel (Sikuler et al, 1997) and the
USA (Zuckerman et al, 1997). Herein, infection with HCV was
detected in 26 out of 120 patients with B-cell NHL compared with
7 out of 154 control subjects with other haematological conditions
and 6 out of 114 with non-malignant conditions. No extranodal
NHL in Zuckerman et al (1997), however, was primarily seen in
the liver or salivary glands. In three studies from the UK (Brind et
al, 1996; Hanley et al, 1996; McColl andTait, 1996), on 63, 38 and
38 NHL cases, respectively, no HCV infection was found. Out
of 115 NHL patients who were evaluated in the Netherlands,
only one showed anti-HCV antibodies (Thalen et al, 1997).
Furthermore, the follow-up of 4051 HIV-negative British
haemophiliacs disclosed a 19-fold excess ofliver cancer death, but
no excess ofNHL mortality (Darby et al, 1995). Possible explana-
tions for the lack of association in northern Europe include many-
fold lower HCV prevalence in the general population and, among
HIV-negative haemophiliacs (Darby et al, 1995), late introduction
ofhaemoderivates at risk ofHCV (Galli et al, 1996). International
differences in the distribution of various HCV genotypes (IARC,
1994) or other cofactors can also be hypothesized.
As the proportion of NHL attributable to established or
suspected causes is very small (Hartge and Devesa, 1992), and a
role of viruses in lymphomagenesis is plausible (Scherr and
Mueller, 1996), HCV currently represents one of the most inter-
esting candidates for at least a fraction ofNHL. In the presence of
liver or salivary gland localizations, when a relation similar to that
for HCC has been found, search for HCV infection may be partic-
ularly appropriate.
ACKNOWLEDGEMENTS
This study was conducted within the framework of the CNR
(Italian National Research Council) Applied Project 'Clinical
Applications of Oncological Research' (contract no.
96.00701.PF39) and with the contribution of the Italian
Association for Research on Cancer. We thank Dr C Scarabelli and
Dr G Tosolini for their help and Mrs I Calderan and T Angelin for
technical assistance.
REFERENCES
Agnello V (1995) The aetiology ofmixed cryoglobulinaemia associated with
hepatitis C virus infection. ScandJImmunol 42: 179-184
Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini
G and the Dionysos Study Group (1994) Prevalence ofchronic liver disease in
the general population ofnorthern Italy: the Dionysos Study. Hepatology 20:
1442-1449
Breslow NE and Day NE (1980) Statistical Methods in Cancer Research. Vol. I. The
analysis ofcase-control studies. IARC Sci. Publ. no. 32. IARC: Lyon
Brind AM, Watson JP, Burt A, Kestevan P, Wallis J, Proctor SJ and Bassendine MF
(1996) Non-Hodgkin's lymphoma and hepatitis C virus infection. Leuk
Lymphoma 21: 127-130
Cavanna L, Sbolli G, Tanzi E, Roman6 L, Civardi G, Buscarini E, Vallisa D, Berte R
and Rossi A (1995) High prevalence ofantibodies to hepatitis C virus in
patients with lymphoproliferative disorders. Haematologica 80: 486-487
British Journal ofCancer (1998) 77(11), 2032-2035 C)CancerResearch Campaign 1998Hepatitis C virus andnon-Hodgkin's lymphomas 2035
Darby SC, Ewart DW, Giangrande PLF, Dolin PJ, Spooner RJD and Rizza CR on
behalfofthe UK Haemophilia Centre Directors Organization (1995) Mortality
before and after HIV infection in the complete UK population of
haemophiliacs. Nature 377: 79-82
De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, Grigioni W,
Alberti A, Beaugrand M, Pisi E, Br6chot C and Paterlini P (1995) HCV-
associated liver cancer without cirrhosis. Lancet 345: 413-415
De Rosa G, Gobbo ML, De Renzo A, Notaro R, Garofalo S, Grimaldi M, Apuzzo A,
Chiurazzi F, Picardi M, Matarazzo M and Rotoli B (1997) High prevalence of
hepatitis C virus infection in patients with B-cell lymphoproliferative disorders
in Italy. Am JHematol 55: 77-82
De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Comacchiulo V,
Santini G, Crovatto M, Gloghini A, Dammacco F and Boiocchi M (1995)
Hepatitis C virus within a malignant lymphoma lesion in the course oftype II
mixed cryoglobulinemia. Blood86: 1887-1892
De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M, Santini G,
Dolcetti R, Boiocchi M, Carbone A and Zagonel V (1997) Characterization of
overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 90:
776-782
Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G,
Lombardini F, Greco F, Capochiani E, Mazzoni A, Mazzaro C and Pasero G
(1994) Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
BrJHaematol 88: 392-394
Galli M, Pioltelli P, Zehender G, Monti G and Monteverde A (1996) HCV and
lymphomagenesis. Lancet 348: 275
Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-
Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Foca A and
Piazza M (1997) Prevalence, risk factors, and genotype distribution ofhepatitis
C virus infection in the general population: a community-based survey in
sourthem Italy. Hepatology 26: 1006-1011
Gumber SC and Chopra S (1995) Hepatitis C: a multifaceted disease. Ann Intern
Med 123: 615-620
Hanley J, Jarvis L, Simmonds P, Parker A and Ludlam C (1996) HCV and non-
Hodgkin lymphoma. Lancet 347: 1339
Hartge P and Devesa SS (1992) Quantification ofthe impact ofknown risk factors
on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 52 (suppl):
5566s-5569s
IARC Working Group on the Evaluation ofCarcinogenic Risks to Humans (1994)
IARC Monogr Eval Carcinog Risks Hum Hepatitis Viruses. Vol. 59: IARC:
Lyon. pp. 165-221
Izumi T, Sasaki R, Miura Y and Okamoto H (1996) Primary hepatosplenic
lymphoma. Association with hepatitis C virus infection. Blood87: 5380-5381
Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H, Kurokawa K,
Matsuura Y and Miyamura T (1997) Sialadenitis histologically resembling
Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc
Natl Acad Sci USA 94: 233-236
Luppi M, Longo G, Ferrari MG, Ferrara L, Marasca R, Barozzi P, Morselli M,
Emilia G and Torelli G (1996) Additional neoplasms and HCV infection in
low-grade lymphoma of MALT type. BrJHaematol 94: 373-375
Luppi M, Longo G, Ferrari MG, Ferrara L, Marasca R, Barozzi P, Morselli M,
Emilia G and Torelli G (1997) Prevalence of HCV infection and second
neoplasms in marginal zone lymphomas. BrJ Haematol 96: 873-874
Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R,
Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R and Pozzato
G (1996) Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 94:
544-550
McColl MD and Tait RC (1996) Hepatitis C virus infection in patients with
lymphoproliferative disorders. BrJHaematol 92: 771-772
Monteverde A, Ballare M, Bertoncelli MC, Zigrossi P, Sabattini E, Poggi S and
Pileri S (1995) Lymphoproliferation in type II mixed cryoglobulinemia. Clin
Exp Rheumatol 13: S141-S 147
Musto P, dell'Olio M, Carotenuto M, Mangia A and Andriulli A (1996) Hepatitis C
virus infection: a new bridge between hematologists and gastroenterologists?
Blood88: 752-754
The non-Hodgkin's Lymphomas Pathologic Classification Project (1982) National
Cancer Institute sponsored study ofclassification ofnon-Hodgkin's
lymphomas. Summary and description of a working formulation for clinical
usage. Cancer 49: 2112-2135
Pioltelli P, Zehender G, Monti G, Monteverde A and Galli M (1996) HCV and non-
Hodgkin's lymphoma. Lancet 347: 624-625
Sansonno D, De Vita S, Comacchiulo V, Carbone A, Boiocchi M and Dammacco F
(1996) Detection and distribution ofhepatitis C virus-related proteins in
lymphnodes ofpatients with type II mixed cryoglobulinemia and neoplastic or
non-neoplastic lymphoproliferation. Blood88: 4638-4645
Scherr PA and Mueller NE (1996) Non-Hodgkin's lymphomas. In Cancer
Epidemiology andPrevention, Schottenfeld D and Fraumeni JF Jr. (eds),
pp. 920-945. Oxford University Press: Oxford
Sikuler E, Shnaider A, Zilberman D, Hilzenrat N, Shemer-Avni Y, Neumann L and
Buskila D (1997) Hepatitis C virus infection and extrahepatic malignancies.
J Clin Gastroenterol 24: 87-89
Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E,
Botta GA and Baccarani M (1996) Prevalence ofhepatitis C virus infection in
patients with lymphoproliferative disorders. Blood 87: 4296-4301
Silvestri F, Barillari G, Fanin R, Salmaso F, Infanti L, Zaja F and Baccarani M
(1997) Hepatitis C virus infection (and additional neoplasms) among marginal
zone lymphomas. BrJHaematol 96: 427-428
Thalen DJ, Raemaekers J, Galama J and Cooreman MP (1997) Absence ofhepatitis
C virus infection in non-Hodgkin's lymphoma. BrJ Haematol 96: 880-881
Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M,
Qian DG, Velankar M, Nathwani BN and Fong T-L (1997) Hepatitis C virus
infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 127:
423-428
© Cancer Research Campaign 1998 British Joumal ofCancer(1998) 77(11), 2032-2035